👀 Watchlist Winners: Copy Legendary Investors' Portfolios in One ClickCOPY FOR FREE

Equinox Gold retain Outperform rating post shares issuance

EditorNatashya Angelica
Published 10/10/2024, 09:15 AM
EQX
-

On Thursday, BMO Capital Markets maintained their positive stance on shares of Equinox Gold Corp (NYSE:EQX:CN) (NYSE: EQX), reiterating an Outperform rating and a price target of Cdn$11.00. This affirmation comes after Equinox Gold's issuance of 24.8 million shares through the conversion of a $130 million convertible note and the release of an updated technical report on its Greenstone mine.

The updated report on Greenstone mine revealed a marginally larger reserve and a production profile that aligns with prior expectations. However, it also projected moderately higher costs, with operating expenses approximately 5% above the forecasts of BMO Capital Markets. Despite these adjustments, the mine is on track to reach its full production capacity of 27,000 tonnes per day by 2025.

BMO Capital Markets adjusted their model for Equinox Gold, resulting in a decrease in the net asset value (NAV) of the Greenstone project from $3.34 billion to $3.03 billion. Despite the recalibration, the firm's outlook on the stock remains unchanged, with the Outperform rating and the $11 price target still in effect.

Equinox Gold's share issuance and the recent technical report are significant updates for the company, providing investors with the latest insights into its operational and financial projections. The Greenstone mine continues to be a focal point for the company's growth trajectory as it ramps up towards its anticipated full production in the coming years.

In other recent news, Equinox Gold Corp. announced its Q2 2024 financial results and operational updates. The company reported Q2 revenue of $269 million from the sale of 115,000 ounces of gold, a net income of $204 million, and an adjusted net loss of $6 million. Equinox Gold also updated its 2024 guidance to 655,000-750,000 ounces of gold, with cash costs of $1,305-$1,405 per ounce and all-in sustaining costs of $1,635-$1,735 per ounce.

On the operational front, Equinox Gold acquired the remaining 40% stake in the Greenstone mine, which is expected to reach commercial production by the end of Q3. However, mining at the Arizona Piaba open pit was suspended due to geotechnical issues, affecting the production forecast. The company also transitioned Castle Mountain Phase one to residual leach operations, focusing on the phase two expansion.

These are recent developments, and it's worth noting that Equinox Gold successfully completed financing activities, including a $500 million term loan, to fund the Greenstone acquisition. The company is confident in managing its financial obligations and continues to focus on advancing its projects and maintaining financial stability amidst the uncertainties of mining operations.

InvestingPro Insights

Adding to BMO Capital Markets' positive outlook on Equinox Gold Corp (EQX), recent data from InvestingPro provides additional context for investors. The company's market capitalization stands at $2.57 billion, reflecting its significant presence in the gold mining sector.

Equinox Gold's financial performance shows promise, with revenue reaching $1.09 billion in the last twelve months as of Q2 2024, marking an 8.24% growth. This aligns with an InvestingPro Tip indicating that analysts anticipate sales growth in the current year, supporting BMO's optimistic stance.

Despite the projected higher costs for the Greenstone mine, Equinox Gold maintains profitability. The company's P/E ratio of 7.63 suggests it may be undervalued relative to its earnings. An InvestingPro Tip further reinforces this, noting that net income is expected to grow this year.

It's worth noting that Equinox Gold operates with a significant debt burden, which investors should consider alongside the company's growth prospects. For a more comprehensive analysis, InvestingPro offers 6 additional tips on Equinox Gold, providing deeper insights into the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.